Concentra Group Holdings Parent Inc
NYSE:CON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concentra Group Holdings Parent Inc
NYSE:CON
|
US |
|
Summerset Group Holdings Ltd
NZX:SUM
|
NZ |
|
Zhe Jiang Jian Feng Group Co Ltd
SSE:600668
|
CN |
|
Montebalito SA
MAD:MTB
|
ES |
|
T
|
Tokmanni Group Oyj
OMXH:TOKMAN
|
FI |
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc., often just referred to as Concentra, thrives by specializing in occupational health services within the United States. Imagine a partner that steps in whenever a company needs to ensure its workforce remains healthy and efficient. Concentra does precisely that by offering a comprehensive suite of medical services tailored for the workplace. This includes everything from urgent care, physical therapy, and workplace wellness programs to preventative screenings. These services aren't just about treating injuries after they occur but extending beyond to prevent them in the first place, thereby ensuring minimal downtime for businesses and maximizing employee productivity.
The organization generates revenue primarily from three business lines: workers' compensation care, physical examinations, and drug testing for employers. By aligning closely with businesses, Concentra essentially positions itself as an extension of a company’s human resources and health safety departments, forming contractual agreements to provide ongoing health management services. Concentra benefits financially by establishing these prolonged relationships with corporate clients, who depend on their medical services to maintain a productive, healthy workforce. This continuity affords Concentra stable revenue streams, while their clinics, strategically placed near concentrated business hubs, ensure that they remain accessible for their day-to-day operational engagements.
Concentra Group Holdings Parent Inc., often just referred to as Concentra, thrives by specializing in occupational health services within the United States. Imagine a partner that steps in whenever a company needs to ensure its workforce remains healthy and efficient. Concentra does precisely that by offering a comprehensive suite of medical services tailored for the workplace. This includes everything from urgent care, physical therapy, and workplace wellness programs to preventative screenings. These services aren't just about treating injuries after they occur but extending beyond to prevent them in the first place, thereby ensuring minimal downtime for businesses and maximizing employee productivity.
The organization generates revenue primarily from three business lines: workers' compensation care, physical examinations, and drug testing for employers. By aligning closely with businesses, Concentra essentially positions itself as an extension of a company’s human resources and health safety departments, forming contractual agreements to provide ongoing health management services. Concentra benefits financially by establishing these prolonged relationships with corporate clients, who depend on their medical services to maintain a productive, healthy workforce. This continuity affords Concentra stable revenue streams, while their clinics, strategically placed near concentrated business hubs, ensure that they remain accessible for their day-to-day operational engagements.
Strong Quarter: Concentra finished Q4 and FY2025 with robust results, surpassing the high end of its revenue and adjusted EBITDA guidance.
Revenue Growth: Total revenue grew 15.9% year-over-year in Q4 to $539.1 million, and 13.9% for the full year to $2.2 billion.
Visit Volumes: Patient visits per day in Q4 rose 9% to over 51,000, with organic visit growth even after excluding acquisitions.
Margin Expansion: Adjusted EBITDA margin improved to 17.7% in Q4 and 20% for the year, despite one-time integration and public company costs.
Cash Generation: Free cash flow for the year was $197.8 million, with healthy 114% free cash flow conversion.
2026 Guidance: For FY2026, Concentra expects revenue of $2.25–$2.35 billion, adjusted EBITDA of $450–$470 million, and free cash flow of $200–$225 million.
De Novo & M&A: The company is planning a record 7–9 new center openings in 2026 and will continue small, accretive acquisitions.
Labor & Market Outlook: Labor costs are stable with wage inflation of 2–3%, and management is optimistic about employment trends in their core markets.